These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11858930)

  • 61. Reality bites: a case of severe rattlesnake envenomation.
    Lefkowitz RY; Taylor J; Balfe D
    J Intensive Care Med; 2013; 28(5):314-9. PubMed ID: 22588374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intravascular hemolysis associated with North American crotalid envenomation.
    Gibly RL; Walter FG; Nowlin SW; Berg RA
    J Toxicol Clin Toxicol; 1998; 36(4):337-43. PubMed ID: 9711200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anaphylactoid reaction to rattlesnake envenomation.
    Nordt SP
    Vet Hum Toxicol; 2000 Feb; 42(1):12. PubMed ID: 10670078
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of antivenin dose on outcome from crotalid envenomation.
    Peterson ME
    J Vet Emerg Crit Care (San Antonio); 2010 Oct; 20(5):471. PubMed ID: 20955296
    [No Abstract]   [Full Text] [Related]  

  • 65. Antivenin-related serum sickness.
    Huang CY; Hung DZ; Chen WK
    J Chin Med Assoc; 2010 Oct; 73(10):540-2. PubMed ID: 21051032
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A randomized multicenter trial of Crotalidae polyvalent immune F(ab) antivenom for the treatment of rattlesnake envenomation in dogs.
    Peterson ME; Matz M; Seibold K; Plunkett S; Johnson S; Fitzgerald K
    J Vet Emerg Crit Care (San Antonio); 2011 Aug; 21(4):335-45. PubMed ID: 21827591
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Complications of Crotalidae antivenin therapy.
    Jurkovich GJ; Luterman A; McCullar K; Ramenofsky ML; Curreri PW
    J Trauma; 1988 Jul; 28(7):1032-7. PubMed ID: 2899649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early infusion of a purified monospecific F(ab')2 antivenom serum for Bothrops lanceolatus bites in Martinique.
    Thomas L; Tyburn B; Lang J; Ketterle J
    Lancet; 1996 Feb; 347(8998):406. PubMed ID: 8598738
    [No Abstract]   [Full Text] [Related]  

  • 70. First new management for poisonous snakebites in more than 50 years is now available. Biotechnology product provides safe and effective therapy for poisonous snake bites.
    Clin Nurse Spec; 2001 May; 15(3):121-3. PubMed ID: 11855461
    [No Abstract]   [Full Text] [Related]  

  • 71. Crotalid envenomation in children: selective conservative management.
    Wagner CW; Golladay ES
    J Pediatr Surg; 1989 Jan; 24(1):128-31, Discussion 131. PubMed ID: 2723986
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Copperhead snakebite treated with crotalidae polyvalent immune fab (ovine) antivenom in third trimester pregnancy.
    Kravitz J; Gerardo CJ
    Clin Toxicol (Phila); 2006; 44(3):353-4. PubMed ID: 16749561
    [No Abstract]   [Full Text] [Related]  

  • 73. The antivenin is safe, but its future is uncertain.
    Galli R
    West J Med; 2001 Aug; 175(2):91-2. PubMed ID: 11483548
    [No Abstract]   [Full Text] [Related]  

  • 74. Significant envenomation from a preserved rattlesnake head (in a patient with a history of immediate hypersensitivity to antivenin).
    Griffen D; Donovan JW
    Ann Emerg Med; 1986 Aug; 15(8):955-8. PubMed ID: 3740586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Efficacy, safety, and use of snake antivenoms in the United States.
    Dart RC; McNally J
    Ann Emerg Med; 2001 Feb; 37(2):181-8. PubMed ID: 11174237
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Southern Pacific Rattlesnake bite: a unique clinical challenge.
    Wasserberger J; Ordog G; Merkin TE
    J Emerg Med; 2006 Oct; 31(3):263-6. PubMed ID: 16982358
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav
    Boels D; Hamel JF; Le Roux G; Labadie M; Paret N; Delcourt N; Langrand J; Puskarczyk E; Nisse P; Sinno-Tellier S; de Haro L
    Clin Toxicol (Phila); 2020 Nov; 58(11):1050-1057. PubMed ID: 32134691
    [No Abstract]   [Full Text] [Related]  

  • 78. Biology and treatment of the mamba snakebite.
    Hodgson PS; Davidson TM
    Wilderness Environ Med; 1996 May; 7(2):133-45. PubMed ID: 11990107
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22).
    Ryan NM; Kearney RT; Brown SG; Isbister GK
    Clin Toxicol (Phila); 2016; 54(1):27-33. PubMed ID: 26490786
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medically significant late bleeding after treated crotaline envenomation: a systematic review.
    Lavonas EJ; Khatri V; Daugherty C; Bucher-Bartelson B; King T; Dart RC
    Ann Emerg Med; 2014 Jan; 63(1):71-78.e1. PubMed ID: 23567063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.